OTF
AVNR

Opus Trading Fund’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Opus Trading Fund’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$110K Buy
+23,888
New +$82.1K 0.21% 39

Other funds holding AVNR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Opus Trading Fund's AVNR Position: Q2 2013 in Review

Opus Trading Fund opened a new position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q2 2013: 23,888 shares worth $110K. The stake represents 0.21% of the portfolio and ranks #39 among its holdings.

95 funds tracked by Wall St. Rank hold AVNR as of Q2 2013.

  • Opus Trading Fund held 23,888 shares of AVANIR PHARMACEUTICALS, INC CL A worth $110K as of Q2 2013.
  • AVANIR PHARMACEUTICALS, INC CL A was a new Opus Trading Fund position in Q2 2013.
  • AVANIR PHARMACEUTICALS, INC CL A made up 0.21% of Opus Trading Fund's portfolio in Q2 2013, its #39 holding.
  • 95 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q2 2013.

Based on Opus Trading Fund's 13F filing for Q2 2013, filed 5 Aug 2013.